ArticleMolecular therapy. Nucleic acids2019

Development of a Monomeric Inhibitory RNA Aptamer Specific for FGFR3 that Acts as an Activator When Dimerized.

Nachiket Kamatkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.